Healthcare provider profile · identity verified

Ariana Smith, FNP

Nurse Practitioner · FAIRBANKS, AK · NPI 1992410237

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	381	128
Losartan Potassium	Losartan Potassium	266	90
Amlodipine Besylate	Amlodipine Besylate	238	84
Rosuvastatin Calcium	Rosuvastatin Calcium	216	83
Lisinopril	Lisinopril	198	66
Levothyroxine Sodium	Levothyroxine Sodium	184	64
Omeprazole	Omeprazole	182	57
Gabapentin	Gabapentin	160	55
Albuterol Sulfate Hfa	Albuterol Sulfate	128	68
Metoprolol Succinate	Metoprolol Succinate	127	50
Tamsulosin Hcl	Tamsulosin Hcl	105	35
Carvedilol	Carvedilol	92	32
Eliquis	Apixaban	92	28
Famotidine	Famotidine	88	38
Metformin Hcl	Metformin Hcl	81	31
Escitalopram Oxalate	Escitalopram Oxalate	80	23
Sertraline Hcl	Sertraline Hcl	79	28
Hydrochlorothiazide	Hydrochlorothiazide	77	26
Furosemide	Furosemide	76	34
Pregabalin	Pregabalin	76	18
Pantoprazole Sodium	Pantoprazole Sodium	71	24
Prednisone	Prednisone	66	34
Duloxetine Hcl	Duloxetine Hcl	64	16
Trazodone Hcl	Trazodone Hcl	60	18
Allopurinol	Allopurinol	59	20
Montelukast Sodium	Montelukast Sodium	58	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	18
Celecoxib	Celecoxib	50	19
Clopidogrel	Clopidogrel Bisulfate	48	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	48	18
Ezetimibe	Ezetimibe	47	18
Esomeprazole Magnesium	Esomeprazole Magnesium	46	19
Finasteride	Finasteride	44	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	14
Tizanidine Hcl	Tizanidine Hcl	44	12
Citalopram Hbr	Citalopram Hydrobromide	41	11
Spironolactone	Spironolactone	39	15
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Tramadol Hcl	Tramadol Hcl	38	13
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	37	suppressed
Simvastatin	Simvastatin	33	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Meloxicam	Meloxicam	32	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	11
Atenolol	Atenolol	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	18
Metformin Hcl Er	Metformin Hcl	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	18
Chlorthalidone	Chlorthalidone	30	suppressed
Ozempic	Semaglutide	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	12
Dicyclomine Hcl	Dicyclomine Hcl	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	27	suppressed
Jardiance	Empagliflozin	27	11
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Potassium Chloride	Potassium Chloride	24	11
Warfarin Sodium	Warfarin Sodium	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Baclofen	Baclofen	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Diazepam	Diazepam	21	11
Fosinopril Sodium	Fosinopril Sodium	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Epinephrine	Epinephrine	20	18
Ibuprofen	Ibuprofen	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Budesonide Dr	Budesonide	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	12
Trulicity	Dulaglutide	18	suppressed
Azithromycin	Azithromycin	17	17
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Armour Thyroid	Thyroid,pork	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	13
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	12
Valsartan	Valsartan	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Atrovent Hfa	Ipratropium Bromide	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Entacapone	Entacapone	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	12	suppressed
Estradiol	Estradiol	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error